151 related articles for article (PubMed ID: 36752299)
1. Shikimate Kinase Inhibitors: An Update on Promising Strategy against
Rajput VS; Runthala A; Khan IA
Curr Drug Targets; 2023; 24(5):388-405. PubMed ID: 36752299
[TBL] [Abstract][Full Text] [Related]
2. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
3. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM
J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel antimicrobial compounds targeting Mycobacterium tuberculosis shikimate kinase using in silico hierarchical structure-based drug screening.
Kawamoto S; Hori C; Taniguchi H; Okubo S; Aoki S
Tuberculosis (Edinb); 2023 Jul; 141():102362. PubMed ID: 37311288
[TBL] [Abstract][Full Text] [Related]
6. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
7. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
[TBL] [Abstract][Full Text] [Related]
8. An overview of mechanism and chemical inhibitors of shikimate kinase.
Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK
J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
12. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
[TBL] [Abstract][Full Text] [Related]
13. Toxicological Profiling of Potential Shikimate Kinase Inhibitors Against
Jhangiani A; Panda V; Sukheja A; Thomas S; Dusseja P; Pandya S; Chintakrindi A
Altern Lab Anim; 2024 Jan; 52(1):10-27. PubMed ID: 38095084
[TBL] [Abstract][Full Text] [Related]
14. Shikimate kinase: a potential target for development of novel antitubercular agents.
Pereira JH; Vasconcelos IB; Oliveira JS; Caceres RA; de Azevedo WF; Basso LA; Santos DS
Curr Drug Targets; 2007 Mar; 8(3):459-68. PubMed ID: 17348838
[TBL] [Abstract][Full Text] [Related]
15. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency.
Sahu PK; Mohapatra PK; Rajani DP; Raval MK
Curr Comput Aided Drug Des; 2020; 16(5):523-529. PubMed ID: 31654517
[TBL] [Abstract][Full Text] [Related]
16. Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.
Vianna CP; de Azevedo WF
J Mol Model; 2012 Feb; 18(2):755-64. PubMed ID: 21594693
[TBL] [Abstract][Full Text] [Related]
17. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
18. Shikimate kinase, a protein target for drug design.
Coracini JD; de Azevedo WF
Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
[TBL] [Abstract][Full Text] [Related]
19. Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids.
Simithy J; Fuanta NR; Alturki M; Hobrath JV; Wahba AE; Pina I; Rath J; Hamann MT; DeRuiter J; Goodwin DC; Calderón AI
Biochemistry; 2018 Aug; 57(32):4923-4933. PubMed ID: 30063132
[TBL] [Abstract][Full Text] [Related]
20.
Nunes JES; Duque MA; de Freitas TF; Galina L; Timmers LFSM; Bizarro CV; Machado P; Basso LA; Ducati RG
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
